Music shows promise in decreasing delirium in critically ill patients

March 10, 2020

INDIANAPOLIS - It is common for critically ill patients on life support to develop delirium, a form of acute brain failure for which no effective treatment is known. A study from Indiana University School of Medicine and Regenstrief Institute researchers reports that music appears to decrease delirium in patients on mechanical ventilators in the intensive care unit (ICU).

In the study, critically ill individuals who listened to slow-tempo, relaxing music (60 to 80 beats per minute) had decreased need for sedatives, fewer days of delirium and were more awake -- enabling them to receive physical therapy earlier. These results are encouraging and a larger clinical trial is currently underway.

Mechanically ventilated patients -- more than a million adults annually in the United States -- are at increased risk for delirium, which is associated with prolonged ICU stays, higher healthcare costs and increased mortality. The intubated patient experiences pain, anxiety and physiologic stress for which they usually are treated with drugs, which can contribute to delirium. This perpetuates a cycle of pain, anxiety, sedation and delirium.

"Like kidney or heart failure, individuals can develop brain failure, but there is no treatment equivalent to dialysis or the ventilator for brain failure, a condition which can adversely affect an individual's personality and quality of life for years," said Sikandar Khan, D.O., M.S., IU School of Medicine assistant professor of medicine and Regenstrief Institute research scientist, who led the new study. "Recent studies by our group and others have shown that drugs, including commonly prescribed antipsychotics, do not treat delirium or reduce its severity, so we desperately need a non-pharmacologic treatment. Our pilot study shows that music may hold promise to help save patients' brains and allow them to experience less stress while critically ill."

Existence of delirium and delirium severity were assessed twice daily in an Eskenazi Health medical-surgical ICU using the CAM-ICU-7, short for Confusion Assessment Method for the Intensive Care Unit 7, a tool developed by Regenstrief Institute and IU School of Medicine clinician-researchers.

Additionally, the new study is the first to determine the acceptability of music by patients on mechanical ventilators and the feasibility of administering music by non-specialists. Patients who listened to the slower-tempo, relaxing music two hours per day needed less sedation and had more delirium free days. ICU nurses could easily place noise-cancelling headphones and audio players with patients.

The researchers divided ICU patients on mechanical ventilators into three groups. Patients were randomized to (1) slow tempo playlists consisting of piano, guitar, Native American flute sounds and classical music; (2) patient preference for the selection of music (as conveyed by surrogates) or (3) an audio book. Patients in the audiobook arm of the study were further randomized to hear a reading of "Treasure Island," the Harry Potter series, or Dr. Seuss' "Oh the Places You'll Go!" All three audiobooks were chosen for readability, broad appeal, quality of narration and high ratings on commercial websites.

Eighty percent of the patients in the study rated the music enjoyable, duration appropriate and indicated that they liked receiving sessions twice a day. Patients noted music had made them feel more normal and calm as well as giving them a sense of control. Slow-tempo music, which had a significantly greater effect than music selected by patient preference, was also more highly favored by study participants.

By contrast, no matter which of the three books they heard while on the ventilator, patients rated audiobooks poorly, with lower acceptance than music of any type.

"Our work is novel in that we explored the effect of music on critically ill, mechanically ventilated adults age 18 and older, a very different group for whom music and delirium has not been previously studied," added Dr. Sikandar Khan. "It's the first study of its type based on science -- in previous work on biomarkers we had shown that slow-tempo music yielded less stress hormones in blood -- and science won."

"Decreasing Delirium through Music (DDM): A Randomized Pilot Trial," is published in the American Journal of Critical Care. Authors in addition to Dr. Sikandar Khan are Chenjia Xu, PhD; Russell Purpura, M.D.; Sana Durrani, MBBS; Heidi Lindroth, PhD, R.N.; Sophia Wang, M.D.; Sujuan Gao, PhD; Annie Heiderscheit, PhD; Linda Chlan, PhD, R.N.; and Regenstrief Institute Research Scientists Malaz Boustani, M.D., MPH and Babar A. Khan, M.D., M.S. The work was supported by a Regenstrief Innovations award.

Dr. Babar Khan and Dr. Chlan are the primary investigators (PIs) and Dr. Sikandar Khan is an investigator of an ongoing randomized controlled clinical trial that is evaluating the effectiveness of exposure to slow-tempo classical music versus simple noise cancellation in decreasing delirium in older adults. The five-year project is supported by the National Institutes of Health's National Institute on Aging and National Eye Institute.

World Delirium Awareness Day is March 11, 2020.
-end-
About IU School of Medicine

IU School of Medicine is the largest medical school in the U.S. and is annually ranked among the top medical schools in the nation by U.S. News & World Report. The school offers high-quality medical education, access to leading medical research and rich campus life in nine Indiana cities, including rural and urban locations consistently recognized for livability.

About Regenstrief Institute

Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its researchers are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform practice and improve the lives of patients around the globe.

Regenstrief Institute is celebrating 50 years of healthcare innovation. Sam Regenstrief, a successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute's research mission.

About Sikandar Khan, D.O., M.S.

Sikandar Khan is a Regenstrief Institute research scientist and an assistant professor of medicine, IU School of Medicine who focuses on delirium in the Intensive Care Unit and non-pharmacological approaches to the prevention and treatment of this devastating brain failure. He earned a D.O. degree from Des Moines University; M.S. from Indiana University; and B.A. and B.S. from Loyola University.

Regenstrief Institute

Related Delirium Articles from Brightsurf:

Delirium could be an early marker of COVID-19
Delirium accompanied by fever could be an early symptom of COVID-19.

Delirium a key sign of COVID-19 in frail, older people
A new analysis of data from researchers at King's College London using information from the COVID Symptom Study app and patients admitted to St Thomas' Hospital in London, has shown that delirium - a state of acute confusion associated with a higher risk of serious illness and death - is a key symptom of COVID-19 in frail, older people.

Does having Alzheimer's disease and dementia affect severity of delirium?
Recently, researchers published findings from the Better Assessment of Illness (BASIL) study, in the Journal of the American Geriatrics Society.

Scientists find new link between delirium and brain energy disruption
Scientists have discovered a new link between impaired brain energy metabolism and delirium -- a disorienting and distressing disorder particularly common in the elderly and one that is currently occurring in a large proportion of patients hospitalized with COVID-19.

Delirium may cause long term cognitive decline
A new meta-analysis of 24 observational studies from researchers at Columbia University Vagelos College of Physicians and Surgeons found that delirium may cause significant long-term cognitive decline.

Is delirium associated with long-term cognitive decline?
The results of 23 studies were combined to examine whether an episode of delirium is a risk factor for long-term cognitive decline.

Researchers work to better measure delirium severity in older patients
In a study published in Dementia and Geriatric Cognitive Disorder, researchers reported on their effort to improve and validate tools used to assess the severity of a condition called delirium, an acute confusional state often experienced by older hospitalized patients.

Coronavirus infections may lead to delirium and potentially PTSD
People taken ill by coronavirus infections may experience psychiatric problems while hospitalized and potentially after they recover, suggests an analysis of past research led by the UCL Institute of Mental Health with King's College London collaborators, published in The Lancet Psychiatry.

Music shows promise in decreasing delirium in critically ill patients
Mechanically ventilated ICU patients -- more than a million adults annually in the US -- are at increased risk for delirium, which is associated with prolonged ICU stays, higher healthcare costs and increased mortality.

Scientists isolate biomarkers that can identify delirium risk and severity
Regenstrief Institute and Indiana University School of Medicine researchers have identified blood-based biomarkers associated with both delirium duration and severity in critically ill patients.

Read More: Delirium News and Delirium Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.